These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16306948)

  • 1. Neuroscientists put gene therapy into reverse.
    Giles J
    Nature; 2005 Nov; 438(7067):402-3. PubMed ID: 16306948
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive measurement of protein aggregation by mutant huntingtin fragments or alpha-synuclein in the lens.
    Muchowski PJ; Ramsden R; Nguyen Q; Arnett EE; Greiling TM; Anderson SK; Clark JI
    J Biol Chem; 2008 Mar; 283(10):6330-6. PubMed ID: 18167346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein modifies huntingtin aggregation in living cells.
    Herrera F; Outeiro TF
    FEBS Lett; 2012 Jan; 586(1):7-12. PubMed ID: 22119730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The neuroprotective B2 strengthens the aggregation of unfolded protein in Huntington chorea and Parkinson disease].
    Saur O; Stark H
    Pharm Unserer Zeit; 2006; 35(6):474-5. PubMed ID: 17137075
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurodegenerative disease: cut to the chase.
    Ellerby LM; Orr HT
    Nature; 2006 Aug; 442(7103):641-2. PubMed ID: 16900190
    [No Abstract]   [Full Text] [Related]  

  • 6. Huntington's disease: genetics lends a hand.
    Palfi S; Jarraya B
    Nature; 2008 Jun; 453(7197):863-4. PubMed ID: 18488017
    [No Abstract]   [Full Text] [Related]  

  • 7. Huntingtin's critical cleavage.
    Fryer JD; Zoghbi HY
    Nat Neurosci; 2006 Sep; 9(9):1088-9. PubMed ID: 16936769
    [No Abstract]   [Full Text] [Related]  

  • 8. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.
    Sarkar S; Davies JE; Huang Z; Tunnacliffe A; Rubinsztein DC
    J Biol Chem; 2007 Feb; 282(8):5641-52. PubMed ID: 17182613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors.
    Kirik D; Björklund A
    Trends Neurosci; 2003 Jul; 26(7):386-92. PubMed ID: 12850435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease?
    Goldberg MS; Lansbury PT
    Nat Cell Biol; 2000 Jul; 2(7):E115-9. PubMed ID: 10878819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversing neurodegeneration: a promise unfolds.
    Orr HT; Zoghbi HY
    Cell; 2000 Mar; 101(1):1-4. PubMed ID: 10778849
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.
    Zala D; Benchoua A; Brouillet E; Perrin V; Gaillard MC; Zurn AD; Aebischer P; Déglon N
    Neurobiol Dis; 2005 Dec; 20(3):785-98. PubMed ID: 16006135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huntingtin aggregates ask to be eaten.
    Thoreen CC; Sabatini DM
    Nat Genet; 2004 Jun; 36(6):553-4. PubMed ID: 15167929
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurodegenerative disease: neuron protection agency.
    Orr HT
    Nature; 2004 Oct; 431(7010):747-8. PubMed ID: 15483586
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
    Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S
    J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease.
    Van Raamsdonk JM; Murphy Z; Slow EJ; Leavitt BR; Hayden MR
    Hum Mol Genet; 2005 Dec; 14(24):3823-35. PubMed ID: 16278236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.
    Arrasate M; Mitra S; Schweitzer ES; Segal MR; Finkbeiner S
    Nature; 2004 Oct; 431(7010):805-10. PubMed ID: 15483602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between BDNF Val66Met polymorphism and age at onset in Huntington disease.
    Alberch J; López M; Badenas C; Carrasco JL; Milà M; Muñoz E; Canals JM
    Neurology; 2005 Sep; 65(6):964-5. PubMed ID: 16186551
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA.
    Wang YL; Liu W; Wada E; Murata M; Wada K; Kanazawa I
    Neurosci Res; 2005 Nov; 53(3):241-9. PubMed ID: 16095740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal and mutant huntingtin: partners in crime.
    Di Prospero NA; Tagle DA
    Nat Med; 2000 Nov; 6(11):1208-9. PubMed ID: 11062523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.